Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Astena Holdings CoIWKCF 66 EBITDA Margin % is 13.58% as of May. 2026, which is 142% above its 10-year median of 5.62. GuruFocus rates IWKCF with a GF Score™ of 66/100 and a GF Value™ of $2.52. The stock has 3 warning signs investors should review. Among 542 Conglomerates companies, Astena Holdings Co ranks worse than 62.92% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Astena Holdings Co's EBITDA for the
three
months ended in May. 2026 was $15.5 Mil. Astena Holdings Co's Revenue for the
three
months ended in May. 2026 was $113.9 Mil. Therefore, Astena Holdings Co's EBITDA margin for the quarter that ended in May. 2026 was 13.58%.
Astena Holdings Co (OTCPK:IWKCF) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Astena Holdings Co EBITDA Margin % Related Terms
Astena Holdings Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Astena Holdings Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Conglomerates subindustry, Astena Holdings Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Astena Holdings Co EBITDA Margin % vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, Astena Holdings Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Astena Holdings Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Astena Holdings Co (IWKCF) has a EBITDA Margin % of 13.58% as of May. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Astena Holdings Co and its competitors. This is 142% above median its historical median of 5.62. Over the past decade, Astena Holdings Co's EBITDA Margin % has ranged from 1.46 to 8.70. According to the industry distribution chart, Astena Holdings Co ranks #341 out of 542 companies in the Conglomerates industry, placing it in the top 62.9%.
Is Astena Holdings Co's EBITDA Margin % too high?
Astena Holdings Co's current EBITDA Margin % of 13.58% is 142% above median its 10-year median of 5.62. Over the past 10 years, this metric has ranged from a low of 1.46 to a high of 8.70. The Conglomerates industry median EBITDA Margin % is 12.14. Astena Holdings Co's value of 13.58% is 11.9% above this industry median. Based on the distribution chart, Astena Holdings Co ranks #341 out of 542 companies in the Conglomerates industry, which is below the industry midpoint. Overall, Astena Holdings Co has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does Astena Holdings Co's EBITDA Margin % compare to MMM and HON?
According to the Conglomerates industry distribution chart, Astena Holdings Co ranks #341 out of 542 companies for EBITDA Margin %. This places Astena Holdings Co in the lower half of its industry. The industry median EBITDA Margin % is 12.14. Astena Holdings Co's value of 13.58% is 11.9% above this benchmark. Historically, Astena Holdings Co's own EBITDA Margin % has ranged from 1.46 to 8.70 over the past decade. While the company's 10-year median is 5.62 vs. the industry median of 12.14, Astena Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Conglomerates company?
The median EBITDA Margin % among Conglomerates companies is 12.14, based on 542 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Astena Holdings Co's current EBITDA Margin % of 13.58% is 11.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Astena Holdings Co and its competitors. For the Conglomerates industry, the median EBITDA Margin % is 12.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Astena Holdings Co's current EBITDA Margin % is 13.58%, which is 142% above median its own 10-year median of 5.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astena Holdings Co stock overvalued right now?
Astena Holdings Co (IWKCF) has a current EBITDA Margin % of 13.58%. The stock's GF Value™ is $2.52, compared to a current price of $2.25 — trading 10.9% below its estimated fair value. The current EBITDA Margin % is 13.58%, which is 142% above median its 10-year median of 5.62 and 11.9% above the Conglomerates industry median of 12.14. Astena Holdings Co's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Astena Holdings Co (IWKCF), the current EBITDA Margin % is 13.58% as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Astena Holdings Co (IWKCF) Overvalued in 2026?
Based on GuruFocus' analysis, Astena Holdings Co stock appears to be undervalued.
The current stock price of $2.25 is trading 10.9% below its estimated GF Value™ of $2.52.
Key valuation signals for IWKCF:
EBITDA Margin %: 13.58% (142% above median its 10-year median of 5.62)
GF Value™: $2.52 vs. price of $2.25 (10.9% below fair value)
Industry Position: 11.9% above the Conglomerates median (#341 of 542)
No single metric tells the full story. See the IWKCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Astena Holdings Co Ltd formerly Iwaki & Co Ltd is engaged in sale of pharmaceuticals, quasi-medicines, veterinary drugs, and medical equipment. It is also engaged in the sale of raw materials for medicines and cosmetics, health foods, chemicals and synthetic resins.
66GF Score
Get the complete analysis for IWKCF
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IWKCF has been successfully added to your 
